Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)

J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e750-e751. doi: 10.1111/jdv.16605. Epub 2020 Jun 8.

Authors

Z Reguiaï^{1

2}, A C Fougerousse^{2

3}, F Maccari^{2

3}, P A Bécherel^{2

4}

Affiliations

¹ Dermatology Department, Polyclinique Courlancy, Reims, France.
² GEM Resoverneuil.
³ Dermatology Department, Military Hospital Begin, Saint-Mandé, France.
⁴ Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France.

PMID: 32401354
DOI: 10.1111/jdv.16605

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Hidradenitis Suppurativa* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
secukinumab